2019
DOI: 10.1101/582031
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Ribosome profiling at isoform level reveals an evolutionary conserved impact of differential splicing on the proteome

Abstract: AbstractThe differential production of transcript isoforms from gene loci is a key cellular mechanism. Yet, its impact in protein production remains an open question. Here, we describe ORQAS (ORF quantification pipeline for alternative splicing), a new pipeline for the translation quantification of individual transcript isoforms using ribosome-protected mRNA fragments (Ribosome profiling). We found evidence of translation for 40-50% of the expressed transcript isoforms in human… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 63 publications
0
4
0
Order By: Relevance
“…Several models have been proposed to explain what marks a stop codon as authentic, where termination of translation occurs normally, versus a premature termination codon (PTC), which leads to NMD in animals, yeast and plants (Nagy & Maquat, 1998; Amrani et al, 2004; Bühler et al, 2006; Behm-Ansmant et al, 2007; Kérenyi et al, 2008; Singh et al, 2008; Hogg & Goff, 2010; Drechsel et al, 2013; Lloyd et al, 2018). Alternative splicing has a well known role in altering the coding potential of transcripts, but can also alter the translation efficiency of the transcript (Floor & Doudna, 2016; Weatheritt et al, 2016; Blair et al, 2017; Fagg et al, 2017; Reixachs-Sole et al, 2019) or change the stability of transcripts by targeting them to NMD (Jumaa & Nielsen, 1997; Hilleren & Parker, 1999; Lejeune et al, 2001; Lewis et al, 2003; Lareau et al, 2007; Ni et al, 2007; Floor & Doudna, 2016; Reixachs-Sole et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Several models have been proposed to explain what marks a stop codon as authentic, where termination of translation occurs normally, versus a premature termination codon (PTC), which leads to NMD in animals, yeast and plants (Nagy & Maquat, 1998; Amrani et al, 2004; Bühler et al, 2006; Behm-Ansmant et al, 2007; Kérenyi et al, 2008; Singh et al, 2008; Hogg & Goff, 2010; Drechsel et al, 2013; Lloyd et al, 2018). Alternative splicing has a well known role in altering the coding potential of transcripts, but can also alter the translation efficiency of the transcript (Floor & Doudna, 2016; Weatheritt et al, 2016; Blair et al, 2017; Fagg et al, 2017; Reixachs-Sole et al, 2019) or change the stability of transcripts by targeting them to NMD (Jumaa & Nielsen, 1997; Hilleren & Parker, 1999; Lejeune et al, 2001; Lewis et al, 2003; Lareau et al, 2007; Ni et al, 2007; Floor & Doudna, 2016; Reixachs-Sole et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…We utilized RNA-seq and Ribo-seq datasets obtained from 52 common Yoruba individuals among the RNA-seq dataset derived from the GEUVADIS project (Lappalainen et al, 2013) (EMBL-EBI, E-GEUV-1) and the Ribo-seq dataset deposited in GEO under GSE61742 (Battle et al, 2015), respectively. To calculate translational efficiency at the isoform level, trimmed reads were aligned to the de novo transcriptome sequences generated from long-read sequencing for 29 immune cell subsets using STAR (Dobin et al, 2013) as with tools developed for the same purpose (Reixachs-Solé et al, 2020;Wang et al, 2016). Then, we applied generated bam files to the coverageDepth and translationalEfficiency functions with corrections using the maximum translational efficiency value in the 90 most highly ribosome-occupied nucleotides window within the feature in ribosomeProfilingQC R package (Ingolia et al, 2009;Ou J and Hoye M, 2022).…”
Section: Translational Efficiencymentioning
confidence: 99%
“…However, 5′ leaders/3′ trailers are not taken into account here, meaning multiple isoforms that differ only in their noncoding regions would all be annotated as the principal isoform. In an attempt to move away from these heuristic approaches and their shortcomings, software has been developed which takes Ribo‐Seq data into account to do transcript isoform level quantification, that is, Ribomap (Wang, McManus, & Kingsford, ), ORQAS (Reixachs‐Solé, Ruiz‐Orera, Alba, & Eyras, ), and SaTann (Calviello, Hirsekorn, & Ohler, ), see Table . However, these tools assign footprints to different isoforms under the premise that their protein synthesis input is directly proportional to their RNA levels, that is, they are translated with the same efficiency.…”
Section: Differential Gene Expressionmentioning
confidence: 99%